Policy | May 09, 2026
NIPER, Raebareli signs technology transfer pact with Lofty Laboratories
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Subscribe To Our Newsletter & Stay Updated
